Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance

Hidenori Kouso, Ichiro Yoshino, Naoko Miura, Tomoyoshi Takenaka, Taro Oba, Tomofumi Yohena, Atsushi Osoegawa, Fumihiro Shoji, Yoshihiko Maehara

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: hMLH1 and hMSH2 have been implicated to be involved in the DNA mismatch repair (MMR) system. The purpose of this study is to investigate the expression of hMLH1 and hMSH2 DNA MMR proteins in non-small cell lung cancer (NSCLC) tissue and to elucidate their clinical significance. Methods: The hMLH1 and hMSH2 protein expression was evaluated by immunohistochemistry for a consecutive series of 113 NSCLC patients. The expressions of each protein were examined for an association with the clinicopathological variables, including genetic alterations analyzed by high resolution fluorescent microsatellite analysis. Results: Regarding the hMLH1 expression, the MSI-positive patients showed significantly lower scores than the MSI-negative patients. For hMSH2 expression, the patients with a 20 or higher pack-year index (PYI) showed significantly higher scores than the patients with a PYI less than 20. The expression status of proteins did not affect both the disease free and overall survival of the patients. No significant correlation was observed among the scores for the proteins. Conclusions: The expressions of hMLH1 and hMSH2 are independently regulated and play different roles in NSCLC. The genetic instability is possibly due to the reduced expression of hMLH1 protein, and hMSH2 expression is associated with smoking status.

Original languageEnglish
Pages (from-to)377-383
Number of pages7
JournalJournal of Surgical Oncology
Volume98
Issue number5
DOIs
Publication statusPublished - Oct 1 2008

Fingerprint

DNA Mismatch Repair
Non-Small Cell Lung Carcinoma
Proteins
Microsatellite Repeats
Disease-Free Survival
Smoking
Immunohistochemistry

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance. / Kouso, Hidenori; Yoshino, Ichiro; Miura, Naoko; Takenaka, Tomoyoshi; Oba, Taro; Yohena, Tomofumi; Osoegawa, Atsushi; Shoji, Fumihiro; Maehara, Yoshihiko.

In: Journal of Surgical Oncology, Vol. 98, No. 5, 01.10.2008, p. 377-383.

Research output: Contribution to journalArticle

Kouso, Hidenori ; Yoshino, Ichiro ; Miura, Naoko ; Takenaka, Tomoyoshi ; Oba, Taro ; Yohena, Tomofumi ; Osoegawa, Atsushi ; Shoji, Fumihiro ; Maehara, Yoshihiko. / Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance. In: Journal of Surgical Oncology. 2008 ; Vol. 98, No. 5. pp. 377-383.
@article{e9df72ce79af4edbb41784125c7b23b3,
title = "Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance",
abstract = "Background: hMLH1 and hMSH2 have been implicated to be involved in the DNA mismatch repair (MMR) system. The purpose of this study is to investigate the expression of hMLH1 and hMSH2 DNA MMR proteins in non-small cell lung cancer (NSCLC) tissue and to elucidate their clinical significance. Methods: The hMLH1 and hMSH2 protein expression was evaluated by immunohistochemistry for a consecutive series of 113 NSCLC patients. The expressions of each protein were examined for an association with the clinicopathological variables, including genetic alterations analyzed by high resolution fluorescent microsatellite analysis. Results: Regarding the hMLH1 expression, the MSI-positive patients showed significantly lower scores than the MSI-negative patients. For hMSH2 expression, the patients with a 20 or higher pack-year index (PYI) showed significantly higher scores than the patients with a PYI less than 20. The expression status of proteins did not affect both the disease free and overall survival of the patients. No significant correlation was observed among the scores for the proteins. Conclusions: The expressions of hMLH1 and hMSH2 are independently regulated and play different roles in NSCLC. The genetic instability is possibly due to the reduced expression of hMLH1 protein, and hMSH2 expression is associated with smoking status.",
author = "Hidenori Kouso and Ichiro Yoshino and Naoko Miura and Tomoyoshi Takenaka and Taro Oba and Tomofumi Yohena and Atsushi Osoegawa and Fumihiro Shoji and Yoshihiko Maehara",
year = "2008",
month = "10",
day = "1",
doi = "10.1002/jso.21108",
language = "English",
volume = "98",
pages = "377--383",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance

AU - Kouso, Hidenori

AU - Yoshino, Ichiro

AU - Miura, Naoko

AU - Takenaka, Tomoyoshi

AU - Oba, Taro

AU - Yohena, Tomofumi

AU - Osoegawa, Atsushi

AU - Shoji, Fumihiro

AU - Maehara, Yoshihiko

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Background: hMLH1 and hMSH2 have been implicated to be involved in the DNA mismatch repair (MMR) system. The purpose of this study is to investigate the expression of hMLH1 and hMSH2 DNA MMR proteins in non-small cell lung cancer (NSCLC) tissue and to elucidate their clinical significance. Methods: The hMLH1 and hMSH2 protein expression was evaluated by immunohistochemistry for a consecutive series of 113 NSCLC patients. The expressions of each protein were examined for an association with the clinicopathological variables, including genetic alterations analyzed by high resolution fluorescent microsatellite analysis. Results: Regarding the hMLH1 expression, the MSI-positive patients showed significantly lower scores than the MSI-negative patients. For hMSH2 expression, the patients with a 20 or higher pack-year index (PYI) showed significantly higher scores than the patients with a PYI less than 20. The expression status of proteins did not affect both the disease free and overall survival of the patients. No significant correlation was observed among the scores for the proteins. Conclusions: The expressions of hMLH1 and hMSH2 are independently regulated and play different roles in NSCLC. The genetic instability is possibly due to the reduced expression of hMLH1 protein, and hMSH2 expression is associated with smoking status.

AB - Background: hMLH1 and hMSH2 have been implicated to be involved in the DNA mismatch repair (MMR) system. The purpose of this study is to investigate the expression of hMLH1 and hMSH2 DNA MMR proteins in non-small cell lung cancer (NSCLC) tissue and to elucidate their clinical significance. Methods: The hMLH1 and hMSH2 protein expression was evaluated by immunohistochemistry for a consecutive series of 113 NSCLC patients. The expressions of each protein were examined for an association with the clinicopathological variables, including genetic alterations analyzed by high resolution fluorescent microsatellite analysis. Results: Regarding the hMLH1 expression, the MSI-positive patients showed significantly lower scores than the MSI-negative patients. For hMSH2 expression, the patients with a 20 or higher pack-year index (PYI) showed significantly higher scores than the patients with a PYI less than 20. The expression status of proteins did not affect both the disease free and overall survival of the patients. No significant correlation was observed among the scores for the proteins. Conclusions: The expressions of hMLH1 and hMSH2 are independently regulated and play different roles in NSCLC. The genetic instability is possibly due to the reduced expression of hMLH1 protein, and hMSH2 expression is associated with smoking status.

UR - http://www.scopus.com/inward/record.url?scp=53549128950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53549128950&partnerID=8YFLogxK

U2 - 10.1002/jso.21108

DO - 10.1002/jso.21108

M3 - Article

C2 - 18646042

AN - SCOPUS:53549128950

VL - 98

SP - 377

EP - 383

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 5

ER -